BIOTRONIK Creates Broader, Stronger PTA Balloon Portfolio
| By HospiMedica International staff writers Posted on 29 Oct 2013 | 

Image: The Passeo-35 HP 0.9 mm PTA balloon (Photo courtesy of BIOTRONIK).
			
			New high-pressure percutaneous transluminal angioplasty (PTA) balloon lengths offer physicians the potential to dilate longer disease segments in lower limb vessels with fewer balloon inflations.
The Passeo-35 HP 0.9 mm PTA balloon is designed to treat vessel segments that require high pressure (HP) dilatation to efface resistant, often fibrotic stenosis, which are commonly encountered in arteriovenous (AV) access fistulae and grafts. The flexible balloon material is designed to conform to vessel curvature, minimizing vessel straightening during HP inflations. The Passeo-35 HP design aims to minimize axial and radial balloon expansion, avoiding excessive barotraumas, and providing excellent stability during inflation at high-rated burst pressures of up to 2735.7 kPa (27 atmospheres).
The BIOTRONIK Passeo-35 PTA balloon line extension and the Passeo-35 HP PTA balloon, intended for AV dialysis fistulae applications, are now available in lengths of up to 200 mm and in diameters of 3–7 mm. The new additions could help reduce potential barotrauma caused by multiple inflations, and may shorten procedure times. In addition, the Passeo-35 line has an extremely low profile, allowing for balloon compatibility with a 1.67 mm introducer sheath, and an excellent secondary profile.
The Passeo-35 line also has excellent synergies with other 0.889 mm guide wire compatible devices in the portfolio, such as the Dynamic Balloon Expandable Stent, the Astron Self Expanding Stent, and the Pulsar-35 Self Expanding Stent. The Passeo-35 HP is available in diameters from 3–12 mm and in balloon lengths from 20–100 mm. The Passeo-35 PA and Passeo-35 HP line of products is made by BIOTRONIK (Buelach, Switzerland).
“These latest additions to our unique peripheral intervention portfolio underline BIOTRONIK’s commitment to delivering dedicated, innovative devices in line with the needs and expectations of interventional operators,” said Alexander Uhl, vice president of marketing for vascular intervention at BIOTRONIK. “Furthermore, our PTA balloon portfolio is now one of, if not the, strongest and most comprehensive available.”
Related Links:
BIOTRONIK
		
			
			
		
        		        
		        The Passeo-35 HP 0.9 mm PTA balloon is designed to treat vessel segments that require high pressure (HP) dilatation to efface resistant, often fibrotic stenosis, which are commonly encountered in arteriovenous (AV) access fistulae and grafts. The flexible balloon material is designed to conform to vessel curvature, minimizing vessel straightening during HP inflations. The Passeo-35 HP design aims to minimize axial and radial balloon expansion, avoiding excessive barotraumas, and providing excellent stability during inflation at high-rated burst pressures of up to 2735.7 kPa (27 atmospheres).
The BIOTRONIK Passeo-35 PTA balloon line extension and the Passeo-35 HP PTA balloon, intended for AV dialysis fistulae applications, are now available in lengths of up to 200 mm and in diameters of 3–7 mm. The new additions could help reduce potential barotrauma caused by multiple inflations, and may shorten procedure times. In addition, the Passeo-35 line has an extremely low profile, allowing for balloon compatibility with a 1.67 mm introducer sheath, and an excellent secondary profile.
The Passeo-35 line also has excellent synergies with other 0.889 mm guide wire compatible devices in the portfolio, such as the Dynamic Balloon Expandable Stent, the Astron Self Expanding Stent, and the Pulsar-35 Self Expanding Stent. The Passeo-35 HP is available in diameters from 3–12 mm and in balloon lengths from 20–100 mm. The Passeo-35 PA and Passeo-35 HP line of products is made by BIOTRONIK (Buelach, Switzerland).
“These latest additions to our unique peripheral intervention portfolio underline BIOTRONIK’s commitment to delivering dedicated, innovative devices in line with the needs and expectations of interventional operators,” said Alexander Uhl, vice president of marketing for vascular intervention at BIOTRONIK. “Furthermore, our PTA balloon portfolio is now one of, if not the, strongest and most comprehensive available.”
Related Links:
BIOTRONIK
Latest Surgical Techniques News
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
- Micro Imaging Device Paired with Endoscope Spots Cancers at Earlier Stage
Channels
Critical Care
view channel 
                    Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
Monitoring blood flow in the brain is crucial for diagnosing and treating neurological conditions such as stroke, traumatic brain injury (TBI), and vascular dementia. However, current imaging methods like... Read more 
                    AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
For decades, doctors have relied on standardized scoring systems to assess patients with the most common type of heart attack—non-ST-elevation acute coronary syndrome (NSTE-ACS). The GRACE score, used... Read morePatient Care
view channel 
                    Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more 
                    VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more 
                    Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more 
                    First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel 
                    Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel 
                    Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more 
                    B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more 
                    CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more 
                    















 
								

 
								
 
								 
                     
                     
                    